ArticleOncotarget2017

Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase.

Ellen L Weisberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.